Related Experiment Video
Updated: Jun 23, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
High-throughput T-cell epitope discovery through MHC peptide exchange
Sine Reker Hadrup1, Mireille Toebes, Boris Rodenko
1Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Methods in Molecular Biology (Clifton, N.J.)
|April 21, 2009
Summary
Researchers developed a new peptide-MHC (pMHC) technology for rapid, high-throughput production of pMHC complexes. This advance enables faster analysis of T-cell responses to diverse disease antigens.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Recombinant peptide-MHC (pMHC) class I complexes are crucial for analyzing T-cell responses.
- Current methods for producing pMHC complexes are complex and limit antigen diversity.
- High-throughput analysis of T-cell responses requires more efficient pMHC production techniques.
Purpose of the Study:
- To develop a novel MHC peptide exchange technology for high-throughput pMHC complex production.
- To enable the parallel synthesis of thousands of different pMHC complexes rapidly.
- To facilitate the development of high-throughput assays for identifying T-cell responses and disease antigens.
Main Methods:
- Developed a peptide-MHC exchange technology utilizing conditional MHC ligands.
- Implemented parallel production of numerous pMHC complexes within hours.
- Established high-throughput MHC-based assay systems.
Main Results:
- The new technology allows for the parallel production of thousands of distinct pMHC complexes.
- Production time for pMHC complexes is reduced to within hours.
- Enabled the development of high-throughput assay systems for T-cell response analysis.
Conclusions:
- The developed MHC peptide exchange technology significantly enhances the efficiency and scalability of pMHC complex production.
- This innovation supports high-throughput screening of disease-associated proteomes, including pathogen, tumor, and autoimmune antigens.
- The technology is valuable for advancing the study of adaptive T-cell responses and identifying novel disease biomarkers.
Related Concept Videos
Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...

